+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Early complications and implant loss in implant-based breast reconstruction with and without acellular dermal matrix (Tecnoss Protexa®): a comparative study



Early complications and implant loss in implant-based breast reconstruction with and without acellular dermal matrix (Tecnoss Protexa®): a comparative study



European Journal of Surgical Oncology 41(1): 113-119



Acellular dermal matrix (ADM) may improve outcomes in implant-based breast reconstruction, but recent evidence suggests complication rates may be higher when ADM is used. We retrospectively compared early complications and implant loss in implant-based breast reconstruction (BR) with and without ADM to evaluate the safety of the procedure in our centre. Case-notes of consecutive women undergoing implant-based BR from May 2011 to November 2012 were retrospectively reviewed. Data were extracted using a standardised pro-forma and the rate of early complications, major complications and implant loss compared between procedure groups. Forty-six implant-based reconstructions were performed for malignancy (n = 31, 67.4%) or prophylaxis (n = 15, 32.6%) in 31 women over the 18-month study period. ADM (Tecnoss Protexa(®), Tecnoss S.r.l.) was used in 31 (67.4%) cases. There were no differences in patient age, BMI, co-morbidities, smoking or chemotherapy between groups, but patients receiving ADM were more likely to have received radiotherapy prior to their reconstruction (n = 6, 30% vs. n = 0, 0%, p = 0.043). The overall rate of early complications was 26.1% (n = 12) but there was no significant difference between procedure groups (standard-n = 4, 27.7% vs. ADM-n = 8, 25.8%; p = 0.950). There were 2 (4.3%) major complications none of which were associated with ADM use (standard-n = 2, 13.3% vs. ADM-n = 0, 0.0%; p = 0.038). There were 6 (13.0%) implant losses of which 4 were in the ADM group (standard-n = 2, 13.3% vs. ADM-n = 4, 12.9%; p = 0.968). All of these were associated with pre-reconstruction radiotherapy. ADM-assisted implant-based reconstruction with Tecnoss Protexa(®) is safe and may improve outcomes for women by facilitating a single-stage procedure. Robust prospective evaluation is now needed to definitively evaluate the role of ADM in implant-based BR.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052756226

Download citation: RISBibTeXText

PMID: 24011501

DOI: 10.1016/j.ejso.2013.08.016


Related references

Minimizing complications with the use of acellular dermal matrix for immediate implant-based breast reconstruction. Annals of Plastic Surgery 71(5): 464-470, 2014

Implant-based breast reconstruction using acellular dermal matrix and the risk of postoperative complications. Plastic and Reconstructive Surgery 125(2): 429-436, 2010

Infectious complications associated with the use of acellular dermal matrix in implant-based bilateral breast reconstruction. Annals of Plastic Surgery 68(5): 432-434, 2012

Two-stage implant-based breast reconstruction compared with immediate one-stage implant-based breast reconstruction augmented with an acellular dermal matrix: an open-label, phase 4, multicentre, randomised, controlled trial. Lancet. Oncology 18(2): 251-258, 2016

Complications following Nipple-Sparing Mastectomy and Immediate Acellular Dermal Matrix Implant-based Breast Reconstruction-A Systematic Review and Meta-analysis. Plastic and Reconstructive Surgery. Global Open 6(1): E1625, 2018

Sterile "ready-to-use" AlloDerm decreases postoperative infectious complications in patients undergoing immediate implant-based breast reconstruction with acellular dermal matrix. Plastic and Reconstructive Surgery 132(4): 725-736, 2013

Sterile Ready to Use Alloderm Decreases Postoperative Infectious Complications in Patients Undergoing Immediate Implant Based Breast Reconstruction with Acellular Dermal Matrix. Plastic & Reconstructive Surgery 132: 130-131, 2013

Short-term cost-effectiveness of one-stage implant-based breast reconstruction with an acellular dermal matrix versus two-stage expander-implant reconstruction from a multicentre randomized clinical trial. British Journal of Surgery 2019, 2019

Implant-based breast reconstruction with acellular dermal matrix. Plastic and Reconstructive Surgery 130(1): 190e-191e; Author Reply 191e-192e, 2012

Short-Term Complications Associated With Acellular Dermal Matrix-Assisted Direct-to-Implant Breast Reconstruction. Annals of Plastic Surgery 78(1): 35-40, 2016

Does the Use of Acellular Dermal Matrix Increase Postoperative Complications of the First-Stage Reconstruction of Immediate Expander-Implant Breast Reconstruction: A Matched Cohort Study. Annals of Plastic Surgery 79(4): 341-345, 2017

Outcomes of immediate implant-based breast reconstruction using an acellular dermal matrix. European Journal of Surgical Oncology (Ejso) 40(11): S42-S43, 2014

Comparison of implant-based immediate breast reconstruction with and without acellular dermal matrix. Plastic and Reconstructive Surgery 128(5): 403e-410e, 2011

The impact of acellular dermal matrix on complications of breast reconstruction using tissue expander/implant: a meta-analysis. Zhonghua Zheng Xing Wai Ke Za Zhi 29(5): 356-361, 2014

A Meta-analysis of Postoperative Complications of Tissue Expander/Implant Breast Reconstruction Using Acellular Dermal Matrix. Aesthetic Plastic Surgery 39(6): 892-901, 2016